« Back
Home /
BI-847325

BI-847325

Item no.	DCC-DC8401-100mg
Manufacturer	DCChemicals
CASRN	1207293-36-4
Amount	100 mg
Quantity options	100 mg 10 mM x 1 mL in DMSO 1 g 250 mg
Category	Reagents & Chemicals Molecules
Type	Inhibitors
Applications	other
Specific against	other
Purity	>98%
Smiles	O([H])C1=C(/C(/C2C([H])=C([H])C([H])=C([H])C=2[H])=N/C2C([H])=C([H])C(=C([H])C=2[H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])C2C([H])=C([H])C(C#CC(N([H])C([H])([H])C([H])([H])[H])=O)=C([H])C=2N1[H]
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	BI-847325,BI 847325,BI847325
Similar products	1207293-36-4
Available
Manufacturer - Applications	BI-847325 is an orally bioavailable, and selective dual MEK/Aurora kinase inhibitor with IC50 of 3 nM, 25 nM, 15 nM, 25 nM, and 4 nM for Xenopus laevis Aurora B, human Aurora A and Aurora C, as well as human MEK1 and MEK2, respectively. Phase 1.
Storage Conditions	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight	464, 5582
Note	For research and scientific purpose only, not for human use.
Chemical name	(Z)-3-(3-((4-((dimethylamino)methyl)phenylamino)(phenyl)methylene)-2-oxoindolin-6-yl)-N-ethylpropiolamide

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 6/26/2025

Express Delivery: Save 1 days

Compare

Add to wishlist

Recommend by mail